SEC Form 4 · accession 0001104659-26-073488
Astrana Health, Inc. · ASTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Mazdyasni
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 4:20 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001083446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 10, 2026 | A | 4,525 | $0.00 | A | 39,288 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
- F2Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.